Clinical Trials Directory

Trials / Unknown

UnknownNCT03107299

Evaluation of the Impact of 3 Methods of Communication on the Adherence of Methotrexate in Patients With Rheumatoid Arthritis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Methotrexate (MTX) is the first-line treatment for rheumatoid arthritis (RA). Poor adherence of this treatment decreases the control of the disease and the effectiveness of the associated treatments. The aim would be to study the observance of patients with RA and to be able to propose adequate solutions favoring patient compliance and thus the stability of the pathology. For this purpose, 3 methods of communication have been put in place to encourage adherence: usual care by the rheumatologist, sms sending or pharmaceutical maintenance.

Conditions

Interventions

TypeNameDescription
OTHERCommunication methods to encourage adherenceProspective randomized controlled study in intention to treat in open monocentric in 3 arms: all patients benefiting from the current management (medical consultation every 4 to 6 months in the department of rheumatology)

Timeline

Start date
2016-07-01
Primary completion
2017-07-01
Completion
2017-07-01
First posted
2017-04-11
Last updated
2017-04-11

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03107299. Inclusion in this directory is not an endorsement.

Evaluation of the Impact of 3 Methods of Communication on the Adherence of Methotrexate in Patients With Rheumatoid Arth (NCT03107299) · Clinical Trials Directory